Ashley Arthur Woodcock

Chairman at

Axalbion Therapeutics Ltd.

Commercial Services

Health Services

Health Technology

Profile

Mr. Ashley A. Woodcock is a Chairman at Axalbion SA and a Chairman at Axalbion Therapeutics Ltd. He is on the Board of Directors at North West Lung Centre.
Mr. Woodcock was previously employed as a Non-Executive Chairman by Reacta Biotech Ltd.

Ashley Arthur Woodcock active positions

Companies	Position	Start
North West Lung Centre North West Lung Centre Medical/Nursing ServicesHealth Services Provides Other human health activities services	Director/Board Member	-
Axalbion SA	Chairman	-
Axalbion Therapeutics Ltd. Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that developing TRPM8 agonists for the treatment of chronic cough and dry eyes	Chairman	-

All active positions of Ashley Arthur Woodcock

Former positions of Ashley Arthur Woodcock

Companies	Position	End
Reacta Biotech Ltd. Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and supplies oral food materials and technologies to pharmaceuticals	Founder	18/02/2026

See the detail of Ashley Arthur Woodcock's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ashley Arthur Woodcock's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Reacta Biotech Ltd. Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and supplies oral food materials and technologies to pharmaceuticals	Commercial Services
North West Lung Centre North West Lung Centre Medical/Nursing ServicesHealth Services Provides Other human health activities services	Health Services
Axalbion SA
Axalbion Therapeutics Ltd. Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that developing TRPM8 agonists for the treatment of chronic cough and dry eyes	Health Technology